Catalysts for Alembic Pharmaceuticals Inc

METHOTREXATE SODIUM — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

DULOXETINE HYDROCHLORIDE — FDA approval

DAPAGLIFLOZIN — FDA approval

PAROXETINE HYDROCHLORIDE — FDA approval

DOXYCYCLINE HYCLATE — FDA approval

DOXYCYCLINE HYCLATE — FDA approval

CARBAMAZEPINE — FDA approval

CARBAMAZEPINE — FDA approval

FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval

FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval

BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval

BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval

LAMOTRIGINE — FDA approval

EFINACONAZOLE — FDA approval

METRONIDAZOLE — FDA approval

METRONIDAZOLE — FDA approval

FLUOROURACIL — FDA approval

FLUOROURACIL — FDA approval

CARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA) — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

LAMOTRIGINE — FDA approval

DIFLUPREDNATE — FDA approval

Alembic Pharmaceuticals Limited recall (Cls III)

IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval

TRAVOPROST — FDA approval